• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

GREB1 异构体在乳腺癌中独立于 ERα 共激活剂活性调节增殖。

GREB1 isoforms regulate proliferation independent of ERα co-regulator activities in breast cancer.

机构信息

Department of Molecular GeneticsThe Ohio State University, Columbus, Ohio, USA.

The Ohio State UniversityComprehensive Cancer Center, Columbus, Ohio, USA.

出版信息

Endocr Relat Cancer. 2018 Jul;25(7):735-746. doi: 10.1530/ERC-17-0496. Epub 2018 Apr 25.

DOI:10.1530/ERC-17-0496
PMID:29695586
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7158201/
Abstract

Activation of the transcription factor estrogen receptor α (ERα) and the subsequent regulation of estrogen-responsive genes play a crucial role in the development and progression of the majority of breast cancers. One gene target of ERα, growth regulation by estrogen in breast cancer 1 (), is associated with proliferation and regulation of ERα activity in estrogen-responsive breast cancer cells. The gene encodes three distinct isoforms: , and , whose molecular functions are largely unknown. Here, we investigate the role of these isoforms in regulation of ERα activity and proliferation. Interaction between GREB1 and ERα was mapped to the amino terminus shared by all GREB1 variants. Analysis of isoform-specific regulation of ERα activity suggests none of the GREB1 isoforms possess potent co-regulator activity. Exogenous expression of GREB1a resulted in elevated expression of some ER-target genes, independent of ERα activity. Despite this slight specificity of GREB1a for gene regulation, exogenous expression of either GREB1a or GREB1b resulted in decreased proliferation in both ER-positive and ER-negative breast carcinoma cell lines, demonstrating an ER-independent function of GREB1. Interestingly, we show an increase in the expression of GREB1b and GREB1c mRNA in malignant breast tissue compared to normal patient samples, suggesting a selective preference for these isoforms during malignant transformation. Together, these data suggest GREB1a has an isoform-specific function as a transcriptional regulator while all isoforms share an ER-independent activity that regulates proliferation.

摘要

转录因子雌激素受体 α (ERα) 的激活以及随后对雌激素反应基因的调节,在大多数乳腺癌的发生和发展中起着至关重要的作用。ERα 的一个基因靶标,乳腺癌中雌激素生长调节因子 1 (),与雌激素反应性乳腺癌细胞中增殖和 ERα 活性的调节有关。该基因编码三个不同的亚型:、和,其分子功能在很大程度上尚不清楚。在这里,我们研究了这些亚型在调节 ERα 活性和增殖中的作用。GREB1 与 ERα 的相互作用被映射到所有 GREB1 变体共享的氨基末端。对 ERα 活性的同工型特异性调节分析表明,GREB1 同工型均不具有有效的共调节剂活性。GREB1a 的外源性表达导致一些 ER 靶基因的表达升高,而与 ERα 活性无关。尽管 GREB1a 对基因调控具有这种轻微的特异性,但 GREB1a 或 GREB1b 的外源性表达均导致 ER 阳性和 ER 阴性乳腺癌细胞系增殖减少,证明了 GREB1 的 ER 非依赖性功能。有趣的是,我们发现在恶性乳腺组织中与正常患者样本相比,GREB1b 和 GREB1c mRNA 的表达增加,这表明在恶性转化过程中这些亚型存在选择性偏好。总之,这些数据表明 GREB1a 作为转录调节剂具有同工型特异性功能,而所有同工型都具有 ER 非依赖性活性,可调节增殖。

相似文献

1
GREB1 isoforms regulate proliferation independent of ERα co-regulator activities in breast cancer.GREB1 异构体在乳腺癌中独立于 ERα 共激活剂活性调节增殖。
Endocr Relat Cancer. 2018 Jul;25(7):735-746. doi: 10.1530/ERC-17-0496. Epub 2018 Apr 25.
2
PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer.PDZK1和GREB1是在激素反应性乳腺癌中表达的雌激素调节基因。
Cancer Res. 2000 Nov 15;60(22):6367-75.
3
The orphan nuclear receptor LRH-1 and ERα activate GREB1 expression to induce breast cancer cell proliferation.孤儿核受体 LRH-1 和 ERα 激活 GREB1 表达,诱导乳腺癌细胞增殖。
PLoS One. 2012;7(2):e31593. doi: 10.1371/journal.pone.0031593. Epub 2012 Feb 16.
4
Correlation of GREB1 mRNA with protein expression in breast cancer: validation of a novel GREB1 monoclonal antibody.乳腺癌中 GREB1 mRNA 与蛋白表达的相关性:一种新型 GREB1 单克隆抗体的验证。
Breast Cancer Res Treat. 2010 Jul;122(2):371-80. doi: 10.1007/s10549-009-0584-x. Epub 2009 Oct 20.
5
Tamoxifen Resistance in Breast Cancer Is Regulated by the EZH2-ERα-GREB1 Transcriptional Axis.雌激素受体拮抗剂他莫昔芬耐药性的调控机制研究——EZH2-ERα-GREB1 转录轴
Cancer Res. 2018 Feb 1;78(3):671-684. doi: 10.1158/0008-5472.CAN-17-1327. Epub 2017 Dec 6.
6
The transcriptional co-activator NCOA6 promotes estrogen-induced GREB1 transcription by recruiting ERα and enhancing enhancer-promoter interactions.转录共激活因子 NCOA6 通过招募 ERα 和增强增强子-启动子相互作用来促进雌激素诱导的 GREB1 转录。
J Biol Chem. 2019 Dec 20;294(51):19667-19682. doi: 10.1074/jbc.RA119.010704. Epub 2019 Nov 19.
7
Estrogen receptor alpha/beta isoforms, but not betacx, modulate unique patterns of gene expression and cell proliferation in Hs578T cells.雌激素受体α/β亚型,而非βcx,调节Hs578T细胞中独特的基因表达模式和细胞增殖。
J Cell Biochem. 2007 Aug 1;101(5):1125-47. doi: 10.1002/jcb.21205.
8
GREB1 regulates PI3K/Akt signaling to control hormone-sensitive breast cancer proliferation.GREB1 通过调控 PI3K/Akt 信号通路控制激素敏感性乳腺癌增殖。
Carcinogenesis. 2020 Dec 31;41(12):1660-1670. doi: 10.1093/carcin/bgaa096.
9
Long-range activation of GREB1 by estrogen receptor via three distal consensus estrogen-responsive elements in breast cancer cells.雌激素受体通过乳腺癌细胞中三个远端共有雌激素反应元件对GREB1进行远程激活。
Mol Endocrinol. 2007 Nov;21(11):2651-62. doi: 10.1210/me.2007-0082. Epub 2007 Jul 31.
10
FGF2 induces breast cancer growth through ligand-independent activation and recruitment of ERα and PRBΔ4 isoform to MYC regulatory sequences.FGF2 通过配体非依赖性激活以及招募 ERα 和 PRBΔ4 异构体到 MYC 调控序列诱导乳腺癌生长。
Int J Cancer. 2019 Oct 1;145(7):1874-1888. doi: 10.1002/ijc.32252. Epub 2019 Mar 28.

引用本文的文献

1
Regulation of RNA splicing in endometrial tissue and its association with endometriosis.子宫内膜组织中RNA剪接的调控及其与子宫内膜异位症的关联。
iScience. 2025 Jul 24;28(9):113207. doi: 10.1016/j.isci.2025.113207. eCollection 2025 Sep 19.
2
Design, synthesis, and biological evaluation of indole-modified tamoxifen relatives as potent anticancer agents.吲哚修饰的他莫昔芬类似物作为强效抗癌剂的设计、合成及生物学评价
RSC Med Chem. 2023 May 29;14(7):1362-1376. doi: 10.1039/d3md00157a. eCollection 2023 Jul 20.
3
CAXII Is a Surrogate Marker for Luminal Breast Tumors Regulated by ER and GATA3.CAXII是一种由雌激素受体(ER)和GATA3调节的管腔型乳腺肿瘤的替代标志物。
Cancers (Basel). 2022 Nov 6;14(21):5453. doi: 10.3390/cancers14215453.
4
Comprehensive Analysis of GDF10 Methylation Site-Associated Genes as Prognostic Markers for Endometrial Cancer.作为子宫内膜癌预后标志物的GDF10甲基化位点相关基因的综合分析
J Oncol. 2022 Oct 10;2022:7117083. doi: 10.1155/2022/7117083. eCollection 2022.
5
PRMT1, a Key Modulator of Unliganded Progesterone Receptor Signaling in Breast Cancer.PRMT1 是乳腺癌中无配体孕激素受体信号的关键调节因子。
Int J Mol Sci. 2022 Aug 23;23(17):9509. doi: 10.3390/ijms23179509.
6
Combined Estrogen Alpha and Beta Receptor Expression Has a Prognostic Significance for Colorectal Cancer Patients.雌激素α和β受体联合表达对结直肠癌患者具有预后意义。
Front Med (Lausanne). 2022 Mar 14;9:739620. doi: 10.3389/fmed.2022.739620. eCollection 2022.
7
Impact of 6 month conjugated equine estrogen versus estradiol-treatment on biomarkers and enriched gene sets in healthy mammary tissue of non-human primates.6 个月共轭马雌激素与雌二醇治疗对非人类灵长类健康乳腺组织生物标志物和富集基因集的影响。
PLoS One. 2022 Mar 17;17(3):e0264057. doi: 10.1371/journal.pone.0264057. eCollection 2022.
8
GREB1: An evolutionarily conserved protein with a glycosyltransferase domain links ERα glycosylation and stability to cancer.GREB1:一种进化上保守的蛋白,具有糖基转移酶结构域,将 ERα 的糖基化和稳定性与癌症联系起来。
Sci Adv. 2021 Mar 17;7(12). doi: 10.1126/sciadv.abe2470. Print 2021 Mar.
9
GREB1 regulates PI3K/Akt signaling to control hormone-sensitive breast cancer proliferation.GREB1 通过调控 PI3K/Akt 信号通路控制激素敏感性乳腺癌增殖。
Carcinogenesis. 2020 Dec 31;41(12):1660-1670. doi: 10.1093/carcin/bgaa096.
10
Nursing Genetic Research: New Insights Linking Breast Cancer Genetics and Bone Density.护理遗传学研究:连接乳腺癌遗传学与骨密度的新见解
Healthcare (Basel). 2020 Jun 15;8(2):172. doi: 10.3390/healthcare8020172.

本文引用的文献

1
Endocrine treatment in breast cancer: Cure, resistance and beyond.乳腺癌的内分泌治疗:治愈、耐药及其他。
Cancer Treat Rev. 2016 Nov;50:68-81. doi: 10.1016/j.ctrv.2016.08.008. Epub 2016 Sep 7.
2
Cancer RNA-Seq Nexus: a database of phenotype-specific transcriptome profiling in cancer cells.癌症RNA测序关系数据库:癌细胞中特定表型转录组分析数据库。
Nucleic Acids Res. 2016 Jan 4;44(D1):D944-51. doi: 10.1093/nar/gkv1282. Epub 2015 Nov 23.
3
Endocrine resistance in breast cancer--An overview and update.乳腺癌中的内分泌耐药——综述与更新
Mol Cell Endocrinol. 2015 Dec 15;418 Pt 3(0 3):220-34. doi: 10.1016/j.mce.2015.09.035. Epub 2015 Oct 9.
4
Sustained reprogramming of the estrogen response after chronic exposure to endocrine disruptors.长期暴露于内分泌干扰物后雌激素反应的持续重编程。
Mol Endocrinol. 2015 Mar;29(3):384-95. doi: 10.1210/me.2014-1237. Epub 2015 Jan 16.
5
Recurrent read-through fusion transcripts in breast cancer.乳腺癌中的复发性通读融合转录本。
Breast Cancer Res Treat. 2014 Jul;146(2):287-97. doi: 10.1007/s10549-014-3019-2. Epub 2014 Jun 15.
6
17β-estradiol upregulates GREB1 and accelerates ovarian tumor progression in vivo.17β-雌二醇上调 GREB1 并加速体内卵巢肿瘤的进展。
Int J Cancer. 2014 Sep 1;135(5):1072-84. doi: 10.1002/ijc.28741. Epub 2014 Feb 25.
7
Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor.内源性净化揭示 GREB1 是关键的雌激素受体调节因子。
Cell Rep. 2013 Feb 21;3(2):342-9. doi: 10.1016/j.celrep.2013.01.010. Epub 2013 Feb 9.
8
Progression-free survival in ovarian cancer is reflected in epigenetic DNA methylation profiles.卵巢癌的无进展生存期反映在表观遗传 DNA 甲基化谱中。
Oncology. 2011;80(1-2):12-20. doi: 10.1159/000327746. Epub 2011 May 16.
9
Correlation of GREB1 mRNA with protein expression in breast cancer: validation of a novel GREB1 monoclonal antibody.乳腺癌中 GREB1 mRNA 与蛋白表达的相关性:一种新型 GREB1 单克隆抗体的验证。
Breast Cancer Res Treat. 2010 Jul;122(2):371-80. doi: 10.1007/s10549-009-0584-x. Epub 2009 Oct 20.
10
Long-range activation of GREB1 by estrogen receptor via three distal consensus estrogen-responsive elements in breast cancer cells.雌激素受体通过乳腺癌细胞中三个远端共有雌激素反应元件对GREB1进行远程激活。
Mol Endocrinol. 2007 Nov;21(11):2651-62. doi: 10.1210/me.2007-0082. Epub 2007 Jul 31.